Immunocorrecting therapy of allergic dermatitis
2013
Omarbekova, G., Kazakh National Agrarian Univ., Almaty (Kazakhstan) | Muralinov, K., Kazakh National Agrarian Univ., Almaty (Kazakhstan) | Kozinda, O., Latvia Univ. of Agriculture, Jelgava (Latvia) | Makhmutov, A., Kazakh National Agrarian Univ., Almaty (Kazakhstan) | Muralinova, J., Kazakh National Agrarian Univ., Almaty (Kazakhstan
This article summarizes data of determining a therapeutic dose of a new immunocorrecting drug, dermatocytoglobulin, developed by the authors of this study. It has been established that this drug has a therapeutic immunocorrecting effect on allergic dermatitis. Subjects of the study cattle, horses, of Raimbek – Commercial Diary Farm, 56 dogs and 35 cats admitted to a veterinary clinic. It has been established that administration of dermatocytoglobulin in trial groups reduces autoantibody titers until their elimination on the 12th day, dose of 0.2 cm3 per 10 kg while autoantibody titers in control groups were identified on the 30th day.
اظهر المزيد [+] اقل [-]